 Connection
Bradley Corr to Ovarian Neoplasms
This is a "connection" page, showing publications Bradley Corr has written about Ovarian Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.981 |
|
|
|
-
Corr BR, Moroney M, Sheeder J, Eckhardt SG, Sawyer B, Behbakht K, Diamond JR. Survival and clinical outcomes of patients with ovarian cancer who were treated on phase 1 clinical trials. Cancer. 2020 10 01; 126(19):4289-4293.
Score: 0.513
-
Moroney MR, Post MD, Berning AA, Sheeder J, Corr BR. An Evaluation of Frozen Section and Lymph Node Dissection Results for Mucinous Ovarian Tumors. Int J Gynecol Cancer. 2018 01; 28(1):92-98.
Score: 0.430
-
Corr BR, Finlay-Schultz J, Rosen RB, Qamar L, Post MD, Behbakht K, Spillman MA, Sartorius CA. Cytokeratin 5-Positive Cells Represent a Therapy Resistant subpopulation in Epithelial Ovarian Cancer. Int J Gynecol Cancer. 2015 Nov; 25(9):1565-73.
Score: 0.370
-
Corr BR, Mantia-Smaldone G, Cantor J, Livolsi VA, Furth E, Chu CS. Metastatic cholangiocarcinoma to the ovary: a case series. Int J Gynecol Pathol. 2013 Nov; 32(6):562-5.
Score: 0.322
-
Fu S, Corr BR, Culm-Merdek K, Mockbee C, Youssoufian H, Stagg R, Naumann RW, Wenham RM, Rosengarten RD, Benjamin L, Hamilton EP, Moore KN. Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer. J Clin Oncol. 2022 08 10; 40(23):2568-2577.
Score: 0.145
-
McMellen A, Woodruff ER, Corr BR, Bitler BG, Moroney MR. Wnt Signaling in Gynecologic Malignancies. Int J Mol Sci. 2020 Jun 16; 21(12).
Score: 0.127
-
Mantia-Smaldone GM, Corr B, Chu CS. Immunotherapy in ovarian cancer. Hum Vaccin Immunother. 2012 Sep; 8(9):1179-91.
Score: 0.074
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|